The Subcutaneous Biologic Drugs And Affiliated Technologies Market Is Projected To Be Worth Over USD 180 Billion By 2030

>

The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030

Roots Analysis has done a detailed report on Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030” covering key aspects of the industry and identifying future growth opportunities

 

To order this 530+ page report, which features 160+ figures and 190+ tables, please visit this https://www.rootsanalysis.com/reports/view_document/subcutaneous-biologics-delivery/314.html

 

Key Market Insights

  • Eminent representatives from biopharmaceutical companies confirm the rising interest in the concept of subcutaneous drug delivery, highlighting some of the key drivers and upcoming trends in this domain
  • More than 100 subcutaneous biologics have been approved and over 350 such drug candidates are being evaluated in the clinical stages of development, for the treatment of a wide variety of disease indications
  • Antibodies and protein therapeutics represent the majority of subcutaneous biologics that are available / under investigation, designed for use against various therapeutic areas and having different dosing regimens
  • Advances in drug delivery have led to the development of novel technology platforms, enabling the administration of highly viscous formulations, and supporting the development of subcutaneous dosage forms
  • Several technology developers have out-licensed their proprietary platforms to pharmaceutical companies in order to enable them to develop subcutaneous formulations of their approved / pipeline products
  • The increasing interest in this field is reflected in the yearly growth in partnership activity, including a number of licensing and product development deals related to subcutaneous formulations of various drug candidates
  • There are several new and innovative drug delivery systems that facilitate subcutaneous administration; we identified over 300 such systems that are presently available / under development
  • With several self-medication enabling devices, such as wearable injectors and autoinjectors, available in the market, developers are actively differentiating their offerings by incorporating advanced, patient-friendly features
  • The market is anticipated to be worth over USD 180 billion in 2030; the projected opportunity is likely to be distributed across various types of molecules that are developed / being developed for different disease indications
  • Pre-filled syringes continue to dominate the current market of subcutaneous drug delivery systems; technology developers are expected to continue relying on licensing agreements as their primary source of revenues333

 

For more information, please visit https://www.rootsanalysis.com/reports/view_document/subcutaneous-biologics-delivery/314.html or email sales@rootsanalysis.com

 

Table of Contents

 

  1. PREFACE

1.1.                   Scope of the Report

1.2.                   Research Methodology

1.3.                   Chapter Outlines

 

  1. EXECUTIVE SUMMARY

 

  1. INTRODUCTION

3.1.                   Chapter Overview

3.2.                   Types of Therapeutic Molecules

3.3.                   Biologically Derived Therapeutics

3.3.1.                Types of Products

3.3.2.                Routes of Administration and Formulations

3.3.3.                Subcutaneous Formulations

3.3.3.1.             Approaches in Subcutaneous Delivery of Biologics

3.3.3.1.1.          Reformulation

3.3.3.1.2.          Differing Potencies

3.3.3.1.3.          Novel Technologies

Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com

Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis

Share:

Keywords: roots analysis,research,pharma,biotech,analysis,market research,industry reports,business report,global

Comments

Other related blogs

The customers who need to purchase the compartments

By : JK Rowling CBD Gummies

  JK Rowling CBD Gummies The customers who need to purchase the compartments of JK Rowling CBD..


The customers who need to purchase the compartments

By : JK Rowling CBD Gummies

  JK Rowling CBD Gummies The customers who need to purchase the compartments of JK Rowling CBD..


How To Buy An MTP Abortion Pill Kit Online?

By : Privacypillrx

Medication abortion is the process of terminating a pregnancy in the early stage with help of aborti..


The RNAi therapeutics market is anticipated to grow at an annualized rate of more than 45%, till 2030, claims Roots Analysis

By : Roots Analysis

The recent approval of first RNAi therapeutic, ONPATTROTM, has caused a surge in interest of the ind..